Not Tagged
Not Tagged
['prostate']
phase 3 results appear to support intensification of adt in patients with biochemically recurrent prostate cancer. #esmo22
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.